%0 Journal Article
%T Helicobacter pylori Infection and Risk of Lung Cancer: A Meta-Analysis
%A Pulikonda Mounika
%J Lung Cancer International
%D 2013
%I Hindawi Publishing Corporation
%R 10.1155/2013/131869
%X Background. Recent evidence showed that Helicobacter pylori seropositivity is a risk factor for gastric and several other cancers. However, evidence on H. pylori infection and risk of lung cancer has been controversial, with a limited number of underpowered studies. We therefore examined the association between H. pylori infection and risk of lung cancer. Methods. A comprehensive literature search was performed using PubMed, EMBASE (until October 2012) for studies investigating an association between Helicobacter pylori (H. pylori) infection and risk of lung cancer. Pooled odds ratio (OR) was calculated using random-effects model. Subgroup and sensitivity analysis were also done. Results. A total of seven studies (6 case-control and 1 cohort study) were included for the analysis. There was a significant heterogeneity among the studies, but no publication bias was observed. We found that H. pylori infection was associated with significantly increased risk of lung cancer (pooled OR, 2.29 (95% CI, 1.34¨C3.91) ). Conclusions. Our meta-analysis suggests a significant increased risk of lung cancer in patients with H. pylori infection. Further research is needed to confirm these findings and to identify the underlying biological mechanisms. 1. Introduction Lung cancer is the second most common cancer in both men and women. Most recent estimates of American Cancer Society reflect 160,340 deaths due to lung cancer (87,750 in men and 72,590 in women), accounting for about 28% of all cancer deaths in United States [1]. Helicobacter pylori (H. pylori) is one of the most common bacterial infections of humans affecting approximately 50% of the worldĄŻs population [2]. This Gram-negative bacterium infects the human gastric mucosa and causes long-term colonization and inflammation. In a subpopulation of infected individuals, long-term inflammation results in peptic ulcer disease and gastric malignancy [3]. Recent evidence showed that H. pylori seropositivity is also a risk factor for gastric [4], colorectal [5], pancreas [6], and hepatobiliary cancers [7, 8]. An increased seroprevalence was also found in various respiratory diseases like chronic bronchitis [9], asthma [10], and pulmonary tuberculosis [11]. However, evidence on H. pylori infection and risk of lung cancer has been controversial, with a limited number of underpowered studies that report result of increased risk [12¨C14], decreased risk [15], or no association [3, 16, 17] between the H. pylori infection and risk of lung cancer. This issue was discussed in previously conducted meta-analysis that analyzed the
%U http://www.hindawi.com/journals/lci/2013/131869/